| J9271 | Injection, pembrolizumab, 1 mg | 7,600 | $40 | $326.8K |
| J0897 | Injection, denosumab, 1 mg | 2,580 | $20 | $46.4K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 790 | $60 | $44.9K |
| J1627 | Injection, granisetron, extended-release, 0.1 mg | 7,400 | $10 | $37K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 320 | $90 | $30.5K |
| Q5108 | Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | 240 | $100 | $24K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 260 | $80 | $22.2K |
| J0185 | Injection, aprepitant, 1 mg | 10,660 | $1 | $10.7K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 50 | $120 | $6.3K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 180 | $20 | $3.8K |